These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 2516312)

  • 1. Transdermal dual-controlled delivery of contraceptive drugs: formulation development, in vitro and in vivo evaluations, and clinical performance.
    Chien YW; Chien TY; Bagdon RE; Huang YC; Bierman RH
    Pharm Res; 1989 Dec; 6(12):1000-10. PubMed ID: 2516312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transdermal delivery of levonorgestrel.
    Friend DR
    Med Res Rev; 1991 Jan; 11(1):49-80. PubMed ID: 1899713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of gestagens: some problems.
    Fotherby K
    Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 2):323-8. PubMed ID: 2115297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transdermal application of steroid hormones for contraception.
    Sitruk-Ware R
    J Steroid Biochem Mol Biol; 1995 Jun; 53(1-6):247-51. PubMed ID: 7626463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints: clinical and endometrial responses.
    Raudaskoski TH; Lahti EI; Kauppila AJ; Apaja-Sarkkinen MA; Laatikainen TJ
    Am J Obstet Gynecol; 1995 Jan; 172(1 Pt 1):114-9. PubMed ID: 7847516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative study of the effects of an estradiol-releasing vaginal ring combined with an oral gestagen versus transdermal estrogen combined with a levonorgestrel-releasing IUD: clinical findings and endometrial response.
    Kalogirou D; Antoniou G; Karakitsos P; Kalogirou O; Antoniou D; Giannikos L
    Int J Fertil Menopausal Stud; 1996; 41(6):522-7. PubMed ID: 9010746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contraception in hypertensive women using a vaginal ring delivering estradiol and levonorgestrel.
    Elkik F; Basdevant A; Jackanicz TM; Guy-Grand B; Mercier-Bodard C; Conard J; Bardin CW; Corvol P
    J Clin Endocrinol Metab; 1986 Jul; 63(1):29-35. PubMed ID: 3086360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of the contraceptive steroids levonorgestrel and gestodene after single and multiple oral administration to women.
    Kuhnz W
    Am J Obstet Gynecol; 1990 Dec; 163(6 Pt 2):2120-7. PubMed ID: 2124087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of ovarian function with the transdermally given synthetic progestin ST 1435.
    Laurikka-Routti M; Haukkamaa M; Lähteenmäki P
    Fertil Steril; 1992 Oct; 58(4):680-4. PubMed ID: 1426309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of transdermal oestradiol on bleeding pattern, hormonal profiles and sex steroid receptor distribution in the endometrium of Norplant users.
    Boonkasemsanti W; Reinprayoon D; Pruksananonda K; Niruttisard S; Triratanachat S; Leepipatpaiboon S; Wannakrairot P
    Hum Reprod; 1996 Oct; 11 Suppl 2():115-23. PubMed ID: 8982753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transdermal delivery of sex steroids for hormone replacement therapy and contraception. A review of principles and practice.
    Henzl MR; Loomba PK
    J Reprod Med; 2003 Jul; 48(7):525-40. PubMed ID: 12953327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical performance and endocrine profiles with contraceptive vaginal rings containing a combination of estradiol and d-norgestrel.
    Mishell DR; Moore DE; Roy S; Brenner PF; Page MA
    Am J Obstet Gynecol; 1978 Jan; 130(1):55-62. PubMed ID: 619648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relative bioavailability of levonorgestrel and ethinylestradiol when administered in tablet and capsule form.
    Back DJ; Killick SR; Stevenson PJ; Shenoy N; Elstein M; Cohen M
    Contraception; 1987 Sep; 36(3):321-6. PubMed ID: 3119288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transdermal delivery of contraceptives.
    Friend DR
    Crit Rev Ther Drug Carrier Syst; 1990; 7(2):149-86. PubMed ID: 2272099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interaction of phenytoin and carbamazepine with combined oral contraceptive steroids.
    Crawford P; Chadwick DJ; Martin C; Tjia J; Back DJ; Orme M
    Br J Clin Pharmacol; 1990 Dec; 30(6):892-6. PubMed ID: 2126946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transdermal delivery of levonorgestrel. V. Preparation of devices and evaluation in vitro.
    Friend DR; Catz P; Heller J; Okagaki M
    Pharm Res; 1989 Nov; 6(11):938-44. PubMed ID: 2512569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of contraceptive steroids in patients with cystic fibrosis.
    Stead RJ; Grimmer SF; Rogers SM; Back DJ; Orme ML; Hodson ME; Batten JC
    Thorax; 1987 Jan; 42(1):59-64. PubMed ID: 3112991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum pharmacokinetics of orally administered desogestrel and binding of contraceptive progestogens to sex hormone-binding globulin.
    Bergink W; Assendorp R; Kloosterboer L; van Lier W; Voortman G; Qvist I
    Am J Obstet Gynecol; 1990 Dec; 163(6 Pt 2):2132-7. PubMed ID: 2147817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
    Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST
    Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of single and multiple doses of ethinyl estradiol and levonorgestrel in relation to smoking.
    Kanarkowski R; Tornatore KM; D'Ambrosio R; Gardner MJ; Jusko WJ
    Clin Pharmacol Ther; 1988 Jan; 43(1):23-31. PubMed ID: 3121231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.